The findings reveal that elevated levels of p-tau and GFAP are linked to AD pathology, astrocyte reactivity, and neurodegeneration [54], while p-tau181 and NfL correlates with disease progression [55]. The gene discussed is MAPT; the disease is Alzheimer disease.